Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLITRK5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR4500HG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00560 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SP3P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLITRK6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00559 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR622 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01049 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00410 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR17HG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLITRK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00564 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPRY2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00382 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDFIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on